SequelSEC

Ardent Health, Inc. ARDT

Services-General Medical & Surgical Hospitals, NEC · CIK 0001756655 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$6.32B
Fiscal year ended 2025-12-31
Operating income
Unavailable
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

Ardent Health, Inc. (ARDT) reported revenue of $6.32B and net income of $135.81M for the fiscal year ended 2025-12-31. This page shows 4 annual periods of income statement, balance sheet and cash flow figures normalized from Ardent Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-General Medical & Surgical Hospitals, NEC.

Income

Ardent Health, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Revenue$6.32B$5.97B$5.41B$5.13B
Cost of revenueUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailable
Operating incomeUnavailableUnavailableUnavailableUnavailable
Net income$135.81M$210.34M$53.90M$188.91M
Research & developmentUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 141.45Mshares 132.74Mshares 126.12Mshares 126.12M
Pretax income$286.36M$363.06M$151.61M$311.48M
Income tax expense$56.22M$63.35M$22.64M$46.11M
Diluted EPS$0.96$1.58$0.43$1.50
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailable
General & administrative$140.80M$132.40M$114.60M$75.30M
Selling & marketingUnavailableUnavailableUnavailableUnavailable

Balance

Ardent Health, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Cash & equivalents$709.60M$556.78M$437.58MUnavailable
Total assets$5.29B$4.96B$4.73BUnavailable
Current assets$2.06B$1.83B$1.62BUnavailable
Total liabilities$3.61B$3.43B$3.65BUnavailable
Current liabilities$1.05B$945.42M$994.10MUnavailable
Total equity incl. NCI$1.69B$1.52B$1.08B$1.04B
Temporary (mezzanine) equity-$1.25M$1.16M$7.30M$10.80M
Inventory$118.59M$115.09M$105.48MUnavailable
Accounts receivable$686.10M$743.03M$775.45MUnavailable
Goodwill$879.45M$852.08M$844.70M$844.70M
Long-term debt$1.08B$1.09B$1.17BUnavailable
Accounts payable$457.94M$401.25M$474.54MUnavailable

Cash flow

Ardent Health, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Operating cash flow$470.51M$315.03M$221.70M-$38.36M
Capital expendituresUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$214.23M-$220.46M-$137.98M$46.58M
Financing cash flow-$103.46M$24.64M-$102.26M-$270.33M
Net change in cash$152.82M$119.21M-$18.55M-$262.11M
Stock-based compensationUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailable$0$0$174.81M
Common share repurchasesUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$155.70M$146.29M$140.84M$138.17M

Derived

Ardent Health, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailable
Current ratio1.97x1.94x1.63xUnavailable
Revenue YoY growth6.0%10.3%5.5%Unavailable
Net margin2.1%3.5%1.0%3.7%
R&D / revenueUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailable
Long-term debt / equity0.64xUnavailableUnavailableUnavailable
Effective tax rate19.6%17.4%14.9%14.8%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ARDT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-03-16View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

CYH HCA SGRY THC UHS

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.